Filippo Montemurro

19PUBLICATIONS
138CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsModels of care and place of birthHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jan 26, 2026
Role of ctDNA in Predicting the Outcome of Patients with Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Treated with First-line Ribociclib and Letrozole: BioItaLEE Trial.

Giampaolo Bianchini, Luca Malorni, Roberta Caputo

|Jan 11, 2024
Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study.

Marina Elena Cazzaniga, Paolo Pronzato, Domenico Amoroso

|Oct 27, 2023
SNP of Aromatase Predict Long-term Survival and Aromatase Inhibitor Toxicity in Patients with Early Breast Cancer: A Biomarker Analysis of the GIM4 and GIM5 Trials.

Benedetta Conte, Luca Boni, Giancarlo Bisagni

|Jun 08, 2023
Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer.

Luca Licata, Giulia Viale, Mario Giuliano

|Jan 08, 2023
Dysgeusia in Patients with Breast Cancer Treated with Chemotherapy-A Narrative Review.

Marianna Pellegrini, Fabio Dario Merlo, Elena Agnello

|Nov 11, 2022
Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests.

Mariarosaria Saponaro, Luigi Annunziata, Antonella Turla

Pageof 4

Frequent Collaborators

8 joint publications

Lucia Del Mastro

7 joint publications

Fabio Puglisi

3 joint publications

Giampaolo Bianchini

3 joint publications

Anna Sapino